Atypical multiple sclerosis associated with indolent systemic mastocytosis treated by cladribine

被引:0
|
作者
Guillaume-Jugnot, P. [1 ,8 ]
Shor, N. [2 ]
Bielle, F. [3 ,4 ]
Zavanone, C. [5 ]
Barete, S. [6 ,7 ]
Maillart, E. [5 ]
机构
[1] Hop La Pitie Salpetriere, AP HP, Dept Internal Med & Clin Immunol, Paris, France
[2] Hop La Pitie Salpetriere, AP HP, Dept Neuroradiol, Paris, France
[3] Hop La Pitie Salpetriere, AP HP, Dept Neuropathol, Paris, France
[4] Sorbonne Univ, Inst Cerveau & Moelle Epiniere ICM, Inserm, CNRS,UMR S 1127, Paris, France
[5] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Paris, France
[6] Hosp Pitie Salpetriere, AP HP, Unit Dermatol, Paris, France
[7] Hosp Pitie Salpetriere, Reference Ctr Mastocytosis CEREMAST, Paris, France
[8] 47-83 Blvd Hop, F-75651 Paris 13, France
关键词
D O I
10.1016/j.neurol.2023.03.020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:925 / 927
页数:3
相关论文
共 50 条
  • [41] Eyebrow alopecia associated with cladribine treatment for multiple sclerosis
    Budimkic, Maja Stefanovic
    Ivanovic, Jovana
    Momcilovic, Nikola
    Mesaros, Sarlota
    Drulovic, Jelena
    NEUROLOGICAL SCIENCES, 2023, 44 (10) : 3735 - 3736
  • [42] Novel insights into mastocytosis-associated osteoporosis: mast cells in indolent systemic mastocytosis produce bone cytokines
    Rabenhorst, A.
    Christopeit, B.
    Leja, S.
    Gerbaulet, A.
    Kleiner, S.
    Foerster, A.
    Raap, U.
    Wickenhauser, C.
    Hartmann, K.
    EXPERIMENTAL DERMATOLOGY, 2014, 23 (03) : E2 - E2
  • [43] Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets
    Moiola, Lucia
    Riva, Agostino
    Nicoletti, Ferdinando
    Uccelli, Antonio
    Salvetti, Marco
    Battistini, Luca
    Furlan, Roberto
    CURRENT NEUROPHARMACOLOGY, 2022, 20 (10) : 1811 - 1815
  • [44] Eyebrow alopecia associated with cladribine treatment for multiple sclerosis
    Maja Stefanovic Budimkic
    Jovana Ivanovic
    Nikola Momcilovic
    Sarlota Mesaros
    Jelena Drulovic
    Neurological Sciences, 2023, 44 : 3735 - 3736
  • [45] Study of adaptive immunity in subjects with multiple sclerosis treated with cladribine
    Pirronello, Marta
    Picozza, Mario
    Ruggieri, Serena
    Quartuccio, Esmeralda
    Buscarinu, Maria Chiara
    De Masi, Francesca
    Tortorella, Carla
    Salvetti, Marco
    Gasperini, Claudio
    Borsellino, Giovanna
    Battistini, Luca
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 614 - 615
  • [46] Study of B cells in subjects with multiple sclerosis treated with cladribine
    Pirronello, Marta
    Picozza, Mario
    Guerrera, Gisella
    Corbisiero, Silvia
    D'Orso, Silvia
    Verdiani, Alice
    Lista, Beatrice
    Ruggieri, Serena
    Quartuccio, Esmeralda
    Buscarinu, Maria Chiara
    De Masi, Francesca
    Tortorella, Carla
    Salvetti, Marco
    Gasperini, Claudio
    Borsellino, Giovanna
    Battistini, Luca
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1522 - 1522
  • [47] Severe demyelinating brain lesions in a patient with systemic mastocytosis: multiple sclerosis or brain mastocytosis?
    Beigneux, Y.
    Guillaume-Jugnot, P.
    Bielle, F.
    Hermine, O.
    Demeret, S.
    Zavanone, C.
    Barete, S.
    Maillart, E.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 809 - 809
  • [48] Multiple sclerosis associated with systemic sclerosis
    Syngliti-Henrietta Pelidou
    Niki Tsifetaki
    Sotiris Giannopoulos
    Georgia Deretzi
    Paraskevi Voulgari
    Athanassios Kyritsis
    Rheumatology International, 2007, 27 : 771 - 773
  • [49] Multiple sclerosis associated with systemic sclerosis
    Pelidou, Syngliti-Henrietta
    Tsifetaki, Niki
    Giannopoulos, Sotiris
    Deretzi, Georgia
    Voulgari, Paraskevi
    Kyritsis, Athanassios
    RHEUMATOLOGY INTERNATIONAL, 2007, 27 (08) : 771 - 773
  • [50] Reply to: Successful Isatuximab Desensitization in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis
    Gorriz, M. C. Torres
    Cuartero, J. Borras
    Mendez, C. G. Pesantez
    Coronado, C. I. Stein
    Enrique, E.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2024, 34 (03) : 216 - 217